miRNA expression changes during the course of neoadjuvant bevacizumab and chemotherapy treatment in breast cancer

One of the hallmarks of cancer is sustained angiogenesis. Favorable results have been reported in some breast cancer (BC) patients receiving antiangiogenic therapy with bevacizumab (Bev) in combination with chemotherapy, and further knowledge on how Bev can be optimally combined with conventional tr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mol Oncol
Main Authors: Lindholm, Evita Maria, Ragle Aure, Miriam, Haugen, Mads Haugland, Kleivi Sahlberg, Kristine, Kristensen, Vessela N., Nebdal, Daniel, Børresen‐Dale, Anne‐Lise, Lingjærde, Ole Christian, Engebraaten, Olav
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2019
Assuntos:
Research Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6763780/
https://ncbi.nlm.nih.gov/pubmed/31402562
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/1878-0261.12561
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados